$OGNPotential end of a 5 wave pattern here. Looking for some type of retracement. Maybe a start of an "ABC" correction pattern. Taking profit on the "A".
LongNext report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.72 USD
187.00 M USD
6.22 B USD
259.11 M
About Organon & Co.
Sector
Industry
CEO
Joseph T. Morrissey
Website
Headquarters
Jersey City
Founded
2020
IPO date
May 14, 2021
Identifiers
3
ISIN US68622V1061
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Related stocks
Long
$OGN*For share traders only. Not meant for options.
Green: Entry Point
Blue: Start of Week
Red: End of Week
Thumbs Up: Trade Available for Week
$ Amount (Numbers Above): Price Targets
*I don’t believe in sharing strategies or outlooks due to the idea that it could cause someone confusion within. It’
Long
OGN Harmonic: Monthly Deep-Crab Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. OGN has a moderate quantitative fundamental score (Greater than 5) with go
Long
$OGN LongEverything you say
Can be heard through the white noise
And we can never stay up in arms
I think the end of Roe v. Wade is exactly what this ice cube needs.
Long
$OGN - nice move OGN has had a nice move back to ATH. Now I would expect some consolidation and then higher as long as there is not a bad ER. New stock so be careful of traps. Analysts do not favor it really but that does not mean much.
Long
proposed completed WXY long setup for $OGNelliot wave theory = game genie
i almost always need both geometry and fibs to support a proposed count along with divergence confirmation but this time no obvious support from various fib pulls. however even if the count is wrong, very likely to bounce its just a question of how much. 3-4-5 to 1
Long
OGN Major Upside PotentialHello traders / investors, im looking at OGN as a potential swing opportunity to the the upside, its IPO date was June 7th 2021 with an all time high of 38.24 and then sold off followed by a period of consolidation.
The Weekly chart is showing Bull interest is kicking in.
I do not know much abou
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of OGN is 9.26 USD — it has decreased by −5.12% in the past 24 hours. Watch Organon & Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Organon & Co. stocks are traded under the ticker OGN.
OGN stock has risen by 8.05% compared to the previous week, the month change is a 47.22% rise, over the last year Organon & Co. has showed a −15.51% decrease.
We've gathered analysts' opinions on Organon & Co. future price: according to them, OGN price has a max estimate of 12.00 USD and a min estimate of 8.00 USD. Watch OGN chart and read a more detailed Organon & Co. stock forecast: see what analysts think of Organon & Co. and suggest that you do with its stocks.
OGN stock is 6.73% volatile and has beta coefficient of 2.02. Track Organon & Co. stock price on the chart and check out the list of the most volatile stocks — is Organon & Co. there?
Today Organon & Co. has the market capitalization of 2.41 B, it has increased by 14.29% over the last week.
Yes, you can track Organon & Co. financials in yearly and quarterly reports right on TradingView.
Organon & Co. is going to release the next earnings report on Apr 30, 2026. Keep track of upcoming events with our Earnings Calendar.
OGN earnings for the last quarter are 0.63 USD per share, whereas the estimation was 0.73 USD resulting in a −13.34% surprise. The estimated earnings for the next quarter are 0.83 USD per share. See more details about Organon & Co. earnings.
Organon & Co. revenue for the last quarter amounts to 1.51 B USD, despite the estimated figure of 1.53 B USD. In the next quarter, revenue is expected to reach 1.50 B USD.
OGN net income for the last quarter is −205.00 M USD, while the quarter before that showed 160.00 M USD of net income which accounts for 0.00% change. Track more Organon & Co. financial stats to get the full picture.
Yes, OGN dividends are paid quarterly. The last dividend per share was 0.02 USD. As of today, Dividend Yield (TTM)% is 0.86%. Tracking Organon & Co. dividends might help you take more informed decisions.
Organon & Co. dividend yield was 4.74% in 2025, and payout ratio reached 47.41%. The year before the numbers were 7.51% and 33.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 21, 2026, the company has 10 K employees. See our rating of the largest employees — is Organon & Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Organon & Co. EBITDA is 1.60 B USD, and current EBITDA margin is 26.32%. See more stats in Organon & Co. financial statements.
Like other stocks, OGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Organon & Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Organon & Co. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Organon & Co. stock shows the neutral signal. See more of Organon & Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.